Staar Surgical
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 week.
- Recent price momentum is -3.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 7.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation F
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 2,422.0x | Better than 0% |
| Forward P/E | 48.3x | Better than 8% |
| Price / Sales | 4.0x | Better than 29% |
| P/E vs own 5-yr range | 100th pctl | Better than 2% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -5.6% | Better than 11% |
| Net income CAGR (3Y) | 53.4% | Better than 89% |
| Free cash flow CAGR (3Y) | 4.1% | Better than 44% |
Profitability C-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 76.2% | Better than 88% |
| Operating margin | -19.2% | Better than 12% |
| Net margin | -33.6% | Better than 10% |
| Return on equity | -21.7% | Better than 16% |
| Return on invested capital | -20.8% | Better than 13% |
Momentum C
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 4.7% | Better than 83% |
| 6-month return | -25.4% | Better than 22% |
| 12-month return (ex latest month) | -19.7% | Better than 15% |
| Distance below 52-week high | 32.5% | Better than 38% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.5x | Better than 84% |
| Debt to assets | 8.5% | Better than 72% |
| Interest coverage | -107.2x | Better than 5% |
| Free cash flow / net income | 45.4% | Better than 12% |
Analyst View C+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 66.7% | Better than 41% |
| Upside to average target | 22.5% | Better than 37% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 25.03
- Open
- 24.73
- Day range
- 23.87 - 25.08
- Avg price
- 24.30
- Volume
- 585.64K
- Turnover
- 14.23M
- Turnover ratei
- 2.30%
- Volume ratioi
- 1.24
- Amplitudei
- 4.85%
- 52-week rangei
- 15.59 - 35.87
Valuation
- P/Ei
- -14.95
- P/E (TTM)i
- 2,422.00
- P/Bi
- 3.23
- EPSi
- -1.62
- Book value / shi
- 7.49
- Net profit
- -81.33M
- Net assets
- 376.11M
Share structure
- Market cap
- 1.22B
- Float capi
- 616.76M
- Shares out
- 50.20M
- Float sharesi
- 25.46M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
32.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-8.89M net over the window
Short interest
- Shares short
- 3.65M
- % of floati
- 7.28%
- Days to coveri
- 6.76
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Staar Surgical (STAA)?
Staar Surgical last traded at 24.22. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Staar Surgical's market cap?
About 1.22B.
What is the P/E ratio of Staar Surgical?
The trailing twelve-month P/E is 2,422.00, above its own 5-year average of 89.59 — toward the top of its historical range (99.68% percentile). See the Valuation tab for the full history.
Does Staar Surgical pay a dividend?
Staar Surgical does not currently pay a regular dividend.
Is Staar Surgical a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 29.67, which implies 22.5% upside from the current price. This is not investment advice.
What is Staar Surgical's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Staar Surgical a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Staar Surgical discussion 0 comments